Orsin Medical Technology – Gel & Clot ActivatorExtraction & Analysis Solutions
1,Product Description:
Orsin Medical Technology introduces its cutting-edge Gel and Clot Activator, redefining standards in blood sample processing. This innovative solution represents the next generation of serum separation technology, combining rapid clot activation with intelligent barrier separation for unparalleled diagnostic accuracy.
2, Fundamental Parameters
-
| Category |
Specification |
| Clotting Performance |
15-30 min (ambient temp); 10-20 min (37°C accelerated protocol) |
| Gel Properties |
Density: 1.045±0.005 g/cm³; Thermal range: -20°C to 40°C |
| Centrifugation Protocol |
1300-1500 × g for 10 min (standardized separation protocol) |
2. Quality Metrics
| Parameter |
Acceptance Criteria |
Testing Standard |
| Serum Recovery Rate |
≥95% |
CLSI H18-A4 |
| Hemolysis Index |
≤1% (Visual Index ≤100) |
NCCLS H20-A |
| Cellular Contamination |
≤0.1% |
Microscopic Evaluation |
3. Product Configuration
| Feature |
Specification |
| Available Volumes |
1-10mL |
| Draw Volume Accuracy |
±5% of nominal volume |
| Tube Construction |
PET material with Hemogard™ closure system |
4. Regulatory Compliance
| Standard |
Compliance Status |
| Sterility Assurance |
SAL 10⁻⁶ |
| Endotoxin Levels |
<0.05 EU/mL (USP <85>) |
| Shelf Life Validation |
24 months (accelerated aging studies) |
5. Operational Guidelines
| Condition |
Requirement |
| Storage Temperature |
4-30°C (maintain gel integrity) |
| Freezing Conditions |
Prohibited (causes gel barrier compromise) |
| Clinical Applications |
Compatible with major chemistry/immunoassay platforms |
Note:
-
Performance validated per CLSI protocols using fresh human blood samples
-
Not recommended for use with lipemic or hemolyzed specimens (>500mg/dL triglycerides)
-
This revised format:
-
Organizes information into logical categories
-
Highlights critical compliance and performance data
-
Includes practical usage notes
-
Maintains clear differentiation between specifications and testing standards
-
Provides actionable technical guidance for end-users
-
6,Core Technology Highlights
Our advanced serum separation technology features:
Accelerated coagulation (achieved in 15-30 minutes)
Pure serum isolation (proprietary barrier technology)
Specimen integrity protection (hemolysis rate under 1%)
Value-Added Services
We provide complete support solutions including:
Application-specific customization (multiple tube sizes and formulations)
Laboratory competency development (complimentary protocol optimization)
Guaranteed product performance (temperature-controlled distribution network)
Dedicated technical assistance (round-the-clock expert support)
Commitment to Excellence
Through continuous innovation and customer-focused service, we deliver reliable solutions for modern diagnostic workflows.
